Miles Capital’s Eli Lilly LLY Stock Holding History

Miles Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,368	Closed	-$344K	–	183
2016 Q2	$344K	Sell	4,368 -10,268	-70%	-$773K	0.23%	94
2016 Q1	$1.05M	Sell	14,636 -125	-0.8%	-$9.46K	0.71%	29
2015 Q4	$1.24M	Buy	+14,761	New	+$1.22M	0.85%	21
2015 Q3	–	Sell	-17,084	Closed	-$1.43M	–	175
2015 Q2	$1.43M	Sell	17,084 -730	-4%	-$55.6K	0.94%	21
2015 Q1	$1.29M	Sell	17,814 -638	-3%	-$45.4K	0.77%	31
2014 Q4	$1.27M	Buy	+18,452	New	+$1.25M	0.69%	43

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Miles Capital's LLY Position: Q3 2016 in Review

Miles Capital sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 4,368 shares — an estimated $344K sold.

Miles Capital first reported a position in LLY in Q4 2014 and held it in 6 quarters. The position peaked at $1.43M in Q2 2015. 1,177 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

Miles Capital reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
Miles Capital sold 4,368 Eli Lilly shares in Q3 2016, an estimated $344K.
Miles Capital first reported a position in Eli Lilly in Q4 2014 and held it in 6 quarters.
Miles Capital's Eli Lilly position peaked at $1.43M in Q2 2015.
1,177 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Miles Capital's 13F filing for Q3 2016, filed 15 Nov 2016.